J. V. van Loon

发表

Evaluation of novel radiotherapy technologies: what evidence is needed to assess their clinical and cost effectiveness, and how should we get it?

J. V. van Loon, J. Grutters, F. Macbeth, 2012, The Lancet. Oncology.

Microscopic disease extension in three dimensions for non-small-cell lung cancer: development of a prediction model using pathology-validated positron emission tomography and computed tomography features.

Liesbeth Boersma, Angela van Baardwijk, Kenneth Gilhuijs, 2012, International journal of radiation oncology, biology, physics.

Standard of care in high-dose radiotherapy for localized non-small cell lung cancer

W. V. van Elmpt, D. de Ruysscher, S. Peeters, 2017, Acta oncologica.

Visually guided inspiration breath-hold facilitated with nasal high flow therapy in locally advanced lung cancer

E. van Enckevort, W. V. van Elmpt, D. de Ruysscher, 2020, Acta oncologica.

Comparison of SUVmax and SUVpeak based segmentation to determine primary lung tumour volume on FDG PET-CT correlated with pathology data.

M. V. van Herk, K. Gilhuijs, P. Julyan, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Trends in treatment and relative survival among Non-Small Cell Lung Cancer patients in the Netherlands (1990-2014): Disparities between younger and older patients.

M. Janssen-Heijnen, J. V. van Loon, M. Aarts, 2017, Lung cancer.

Total gross tumor volume is an independent prognostic factor in patients treated with selective nodal irradiation for stage I to III small cell lung cancer.

P. Lambin, D. de Ruysscher, A. Dingemans, 2013, International journal of radiation oncology, biology, physics.

Predictors for poor cosmetic outcome in patients with early stage breast cancer treated with breast conserving therapy: Results of the Young boost trial.

H. Bartelink, L. Boersma, E. van Werkhoven, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Factors associated with patient-reported cosmetic outcome in the Young Boost Breast Trial.

H. Bartelink, L. Boersma, E. van Werkhoven, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A traffic light protocol workflow for image-guided adaptive radiotherapy in lung cancer patients.

W. V. van Elmpt, D. de Ruysscher, M. Öllers, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Patterns of treatment and survival among older patients with stage III non-small cell lung cancer.

M. Janssen-Heijnen, A. Dingemans, J. V. van Loon, 2018, Lung cancer.

The Prevention of Brain Metastases in Non-Small Cell Lung Cancer by Prophylactic Cranial Irradiation

D. de Ruysscher, A. Dingemans, B. Ramaekers, 2018, Front. Oncol..

Are PROMs sufficient to record late outcome of breast cancer patients treated with radiotherapy? A comparison between patient and clinician reported outcome through an outpatient clinic after 10years of follow up.

L. Boersma, D. de Ruysscher, D. Ruysscher, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Selective nodal irradiation on basis of (18)FDG-PET scans in limited-disease small-cell lung cancer: a prospective study.

P. Lambin, L. Boersma, D. de Ruysscher, 2010, International journal of radiation oncology, biology, physics.

Stage III Non-Small Cell Lung Cancer in the elderly: Patient characteristics predictive for tolerance and survival of chemoradiation in daily clinical practice.

M. Janssen-Heijnen, A. Dingemans, J. V. van Loon, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Early CT and FDG-metabolic tumour volume changes show a significant correlation with survival in stage I-III small cell lung cancer: a hypothesis generating study.

P. Lambin, W. V. van Elmpt, D. de Ruysscher, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Therapeutic implications of molecular imaging with PET in the combined modality treatment of lung cancer.

Philippe Lambin, Dirk De Ruysscher, Liesbeth Boersma, 2011, Cancer treatment reviews.

Spacers in radiotherapy treatment of prostate cancer: is reduction of toxicity cost-effective?

P. Lambin, B. Ramaekers, B. Vanneste, 2015, Radiotherapy and Oncology.

Metabolic control probability in tumour subvolumes or how to guide tumour dose redistribution in non-small cell lung cancer (NSCLC): an exploratory clinical study.

P. Lambin, H. Aerts, A. Dekker, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

PET imaging of zirconium-89 labelled cetuximab: A phase I trial in patients with head and neck and lung cancer.

P. Lambin, R. Boellaard, L. Dubois, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Set-up verification and 2-dimensional electronic portal imaging device dosimetry during breath hold compared with free breathing in breast cancer radiation therapy.

J. Jager, L. Boersma, A. V. van Baardwijk, 2015, Practical radiation oncology.

Follow-up with 18FDG-PET-CT after radical radiotherapy with or without chemotherapy allows the detection of potentially curable progressive disease in non-small cell lung cancer patients: a prospective study.

P. Lambin, L. Boersma, D. de Ruysscher, 2009, European journal of cancer.

Is Concurrent Chemoradiotherapy Also the Best Treatment for Elderly Patients with Limited-Stage Small Cell Lung Cancer? - What the CONVERT Data Can Tell Us.

A. Dingemans, J. V. van Loon, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Prediction models for treatment-induced cardiac toxicity in patients with non-small-cell lung cancer: A systematic review and meta-analysis

D. de Ruysscher, A. Dekker, A. Traverso, 2022, Clinical and translational radiation oncology.

Comparative evaluation of autocontouring in clinical practice: A practical method using the Turing test

Paul Aljabar, Andre Dekker, Devis Peressutti, 2018, Medical physics.

18FDG-PET-CT in the follow-up of non-small cell lung cancer patients after radical radiotherapy with or without chemotherapy: an economic evaluation.

P. Lambin, L. Boersma, D. de Ruysscher, 2010, European journal of cancer.

The impact of microscopic disease on the tumor control probability in non-small-cell lung cancer.

Christian Siedschlag, Liesbeth Boersma, Judith van Loon, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

18FDG-PET based radiation planning of mediastinal lymph nodes in limited disease small cell lung cancer changes radiotherapy fields: a planning study.

Philippe Lambin, Geert Bosmans, André Dekker, 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Timed Get Up and Go Test and Geriatric 8 Scores and the Association With (Chemo-)Radiation Therapy Noncompliance and Acute Toxicity in Elderly Cancer Patients.

H. Maas, H. Struikmans, J. V. van Loon, 2017, International journal of radiation oncology, biology, physics.

Impaired Geriatric 8 Score is Associated with Worse Survival after Radiotherapy in Older Patients with Cancer.

E. D. Geijsen, H. Maas, H. Struikmans, 2020, Clinical oncology (Royal College of Radiologists (Great Britain)).

Study Protocol of the NVALT25‐ELDAPT Trial: Selecting the Optimal Treatment for Older Patients With Stage III Non–small‐cell Lung Cancer

M. Janssen-Heijnen, H. Maas, A. Dingemans, 2018, Clinical lung cancer.

Treatment planning and 4D robust evaluation strategy for proton therapy of lung tumors with large motion amplitude

M. Velders, D. Hattu, J. Mannens, 2021, Medical physics.

Comparison of SUVmax and SUVpeak based segmentation to determine primary lung tumour volume on FDG PET-CT correlated with pathology data.

M. V. van Herk, K. Gilhuijs, P. Julyan, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

PET imaging of zirconium-89 labelled cetuximab: A phase I trial in patients with head and neck and lung cancer.

P. Lambin, R. Boellaard, L. Dubois, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Spacers in radiotherapy treatment of prostate cancer: is reduction of toxicity cost-effective?

P. Lambin, B. Ramaekers, B. Vanneste, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.